{"meta":{"query_hash":"9373f12a084b","filters":{"venue":"touchREVIEWS in Neurology"},"cohort_total":15,"direct_labels_cover":0,"predictions_cover":15,"exported":15,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9373f12a084b","api":"https://metacan.xera.ac/api/v1/cohort?venue=touchREVIEWS+in+Neurology"},"results":[{"id":"W2482237976","doi":"10.17925/usn.2015.11.01.19","title":"Physical Activity in Pediatric Multiple Sclerosis—Can Lifestyle Factors Affect Disease Outcomes?","year":2015,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Public Health Agency; Dairy Farmers of Ontario; Public Health Agency of Canada; EMD Serono; National Multiple Sclerosis Society","keywords":"Medicine; Affect (linguistics); Multiple sclerosis; Depression (economics); Disease; Psychological intervention; Neuroinflammation; Population; Cognition; Physical activity; Physical therapy; Physical medicine and rehabilitation; Clinical psychology; Gerontology; Psychiatry; Psychology; Environmental health; Internal medicine","score_opus":0.1576437093915405,"score_gpt":0.36931030302408674,"score_spread":0.21166659363254625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482237976","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012914346,0.98219955,0.00014636807,0.0031584888,0.00025080334,0.000008885934,0.00012752225,0.0000045172674,0.001189509],"genre_scores_gemma":[0.062350415,0.9351279,0.0004572095,0.0009620228,0.0005767177,0.000034256915,0.00016168549,0.0000051650313,0.00032467177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994023,0.00023799186,0.0000874565,0.00010944968,0.00012322939,0.00003963082],"domain_scores_gemma":[0.99889034,0.0006686141,0.00023033387,0.000026035648,0.0001266843,0.000058072583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008985063,0.0002933018,0.00089673384,0.0010037768,0.00020821716,0.0009765858,0.000388707,0.0006006062,0.0017618285],"category_scores_gemma":[0.0028891086,0.00014503945,0.00056006206,0.0011946589,0.00038769338,0.00067918433,0.00054230564,0.0010238747,0.0003275131],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032969326,0.00020299148,0.09698399,0.017171057,0.001085355,0.00045394688,0.00095819007,0.00031170674,0.0008214113,0.0022658652,0.009659476,0.8697564],"study_design_scores_gemma":[0.000077167686,0.0009733494,0.71617454,0.04931118,0.002575655,0.0028050153,0.0023672183,0.00039854474,0.00087500754,0.0049674255,0.21939096,0.00008400248],"about_ca_topic_score_codex":0.0031062798,"about_ca_topic_score_gemma":0.0043725627,"teacher_disagreement_score":0.0031062798,"about_ca_system_score_codex":0.00044290503,"about_ca_system_score_gemma":0.0005100345,"threshold_uncertainty_score":0.0061763525},"labels":[],"label_agreement":null},{"id":"W2487736606","doi":"10.17925/usn.2015.11.01.47","title":"Chronic Inflammatory Demyelinating Polyneuropathy in Diabetes Patients","year":2015,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; University Health Network","funders":"Eisai; Grifols; CSL Behring; Pfizer; Eli Lilly and Company","keywords":"Medicine; Chronic inflammatory demyelinating polyneuropathy; Polyneuropathy; Weakness; Diabetes mellitus; Polyradiculoneuropathy; Pathophysiology; Internal medicine; Nerve conduction velocity; Gastroenterology; Surgery; Pediatrics; Guillain-Barre syndrome; Immunology; Antibody; Endocrinology","score_opus":0.01984212578548503,"score_gpt":0.2651941285470983,"score_spread":0.24535200276161326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487736606","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10877984,0.80163467,0.00046614115,0.026998727,0.0026828896,0.00007494664,0.000764564,0.00008434428,0.058514003],"genre_scores_gemma":[0.4380163,0.53458774,0.0010715486,0.010599742,0.00499009,0.00007746778,0.0011529691,0.000014526284,0.009489489],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998054,0.00005790204,0.00002929895,0.000021427864,0.00003952502,0.00004642295],"domain_scores_gemma":[0.99970573,0.000065810484,0.000073306845,0.000008057161,0.00004227912,0.00010475565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035046716,0.0002092776,0.00032653412,0.00057894393,0.00037524215,0.000548167,0.00016438142,0.00050067814,0.0054946295],"category_scores_gemma":[0.00079597527,0.00007969709,0.00017234561,0.0010722255,0.00015958033,0.00035635303,0.0003963488,0.00055680645,0.0007902289],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043628665,0.00017962669,0.35829914,0.002458663,0.00018760982,0.0060186,0.00083460315,0.00014478172,0.0015920365,0.0021275824,0.09735888,0.5303622],"study_design_scores_gemma":[0.000098025375,0.00026147367,0.6733474,0.0055306326,0.00022701135,0.024454737,0.0015052628,0.00016647759,0.00037832482,0.0025212166,0.29147968,0.000029646173],"about_ca_topic_score_codex":0.0022635788,"about_ca_topic_score_gemma":0.0026509066,"teacher_disagreement_score":0.0054946295,"about_ca_system_score_codex":0.0003291169,"about_ca_system_score_gemma":0.00043596397,"threshold_uncertainty_score":0.018381357},"labels":[],"label_agreement":null},{"id":"W2490618669","doi":"10.17925/usn.2014.10.02.90","title":"Magnetic Resonance Imaging and Dopamine Transporter Single Photon Emission Tomography in Parkinson’s Disease—When Should We Use Them?","year":2014,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Magnetic resonance imaging; Dopamine transporter; Parkinson's disease; Disease; Medical diagnosis; Dopamine; Radiology; Pathology; Internal medicine; Dopaminergic","score_opus":0.03341976575299417,"score_gpt":0.2601324053259612,"score_spread":0.22671263957296706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490618669","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022937718,0.8431636,0.0005837608,0.1410184,0.009059974,0.000015127153,0.000036197183,0.000036621037,0.0037925553],"genre_scores_gemma":[0.031213904,0.866509,0.0032112023,0.053087458,0.042158242,0.000050236325,0.000072546325,0.000049124763,0.0036483018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686855,0.0013225069,0.0004553351,0.0001835082,0.0010261575,0.00014392559],"domain_scores_gemma":[0.98782897,0.006782977,0.0010364117,0.00043800307,0.0030714306,0.00084225443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074973945,0.00075509,0.0020383843,0.001916003,0.0008910304,0.0030432367,0.0012320153,0.0056955204,0.0031623903],"category_scores_gemma":[0.021984318,0.0005573122,0.00077606254,0.0010448935,0.0022742718,0.0051866905,0.0011024416,0.0068387007,0.0017929929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049241725,0.00016764825,0.015982667,0.003009156,0.00058251293,0.00330445,0.00047624414,0.00023303018,0.0013971907,0.007953668,0.26930636,0.69709474],"study_design_scores_gemma":[0.00023585948,0.0005152122,0.04379224,0.021899655,0.0007712963,0.01416516,0.0022877057,0.00065257086,0.0007584953,0.030080259,0.88461334,0.00022818639],"about_ca_topic_score_codex":0.0030478335,"about_ca_topic_score_gemma":0.0059009907,"teacher_disagreement_score":0.0074973945,"about_ca_system_score_codex":0.0012791466,"about_ca_system_score_gemma":0.0015918775,"threshold_uncertainty_score":0.0396505},"labels":[],"label_agreement":null},{"id":"W2492235344","doi":"10.17925/usn.2014.10.02.2","title":"Pharmacologic Decision-making in the Treatment of Focal Epilepsy—A Critical Comparison of Antiepileptic Drugs","year":2014,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutsche Forschungsgemeinschaft; Eisai; Valeant Pharmaceuticals International; Pfizer; Upsher-Smith; GlaxoSmithKline; Epilepsy Foundation","keywords":"Medicine; Polypharmacy; Epilepsy; Tolerability; Intensive care medicine; Antiepileptic drug; Dosing; Concomitant; Drug; Clinical trial; Psychiatry; Pharmacology; Adverse effect; Surgery; Internal medicine","score_opus":0.050738225822317365,"score_gpt":0.43350169861724114,"score_spread":0.3827634727949238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492235344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071063074,0.93699783,0.0023859376,0.042387977,0.0029525908,0.00016142135,0.00004518812,0.000021087906,0.007941703],"genre_scores_gemma":[0.1251721,0.82257974,0.020716459,0.020666327,0.009046133,0.000429987,0.00014425257,0.00004234107,0.0012027394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9721701,0.018914271,0.0033483487,0.00078111026,0.0042341347,0.00055204146],"domain_scores_gemma":[0.9223866,0.063370466,0.0051279673,0.0010490794,0.006006618,0.0020592888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036085185,0.0009098241,0.0029607858,0.002461584,0.001275345,0.007808264,0.0017913551,0.0031789306,0.0032329378],"category_scores_gemma":[0.07350055,0.00045921197,0.0013315876,0.0014208102,0.0028165355,0.0052990764,0.0025596032,0.0045339786,0.00062779145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020972514,0.00025702483,0.0037975193,0.016084341,0.0011823784,0.0016270779,0.0014255279,0.0017104432,0.0008401711,0.03541841,0.03606171,0.8994981],"study_design_scores_gemma":[0.001555982,0.006628171,0.01957167,0.124533944,0.0039341217,0.012306512,0.010207367,0.006220753,0.0032826334,0.11055047,0.70074546,0.00046293763],"about_ca_topic_score_codex":0.0010556107,"about_ca_topic_score_gemma":0.0023354536,"teacher_disagreement_score":0.036085185,"about_ca_system_score_codex":0.005505735,"about_ca_system_score_gemma":0.0075233984,"threshold_uncertainty_score":0.190839},"labels":[],"label_agreement":null},{"id":"W2494387052","doi":"10.17925/usn.2010.06.02.96","title":"Environmental Risk Factors for Pediatric Multiple Sclerosis","year":2010,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Disease; Environmental health; Immunology; Pathology","score_opus":0.02081325690780442,"score_gpt":0.24309421097132322,"score_spread":0.2222809540635188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494387052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4152304,0.54753655,0.002535556,0.0077613285,0.0003342776,0.000036011952,0.00080764404,0.00011373026,0.025644464],"genre_scores_gemma":[0.7236076,0.2670241,0.0030594503,0.00074775267,0.00054781925,0.00003560608,0.0005091197,0.00002244136,0.004445965],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998147,0.00005450941,0.0000134519405,0.000031104588,0.00006173734,0.000024538502],"domain_scores_gemma":[0.99962354,0.00013399318,0.00013929751,0.000010533319,0.00004974803,0.000042865326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022794199,0.0002612197,0.00027854386,0.0005621524,0.00021214715,0.00035262076,0.00014468099,0.00034513028,0.0022445098],"category_scores_gemma":[0.00063490466,0.00008712474,0.0002083663,0.00065842195,0.0001736986,0.00017625692,0.0002565408,0.00046614168,0.00023959501],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017777328,0.00011503932,0.7589133,0.0005746785,0.00033985733,0.0042232345,0.00043144805,0.0004438738,0.003995213,0.0027888198,0.008970113,0.21902667],"study_design_scores_gemma":[0.000009793196,0.00014206336,0.92574126,0.0007606588,0.0003160322,0.010964539,0.00031648055,0.0002602135,0.0011626193,0.0016105819,0.05870068,0.0000150399865],"about_ca_topic_score_codex":0.0023357982,"about_ca_topic_score_gemma":0.0026005607,"teacher_disagreement_score":0.0023357982,"about_ca_system_score_codex":0.00022678073,"about_ca_system_score_gemma":0.00035359382,"threshold_uncertainty_score":0.0075086355},"labels":[],"label_agreement":null},{"id":"W2799778697","doi":"10.17925/usn.2018.14.1.35","title":"Homocysteine Lowering with B Vitamins for Stroke Prevention—A History","year":2018,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Methylcobalamin; Vitamin B12; Cyanocobalamin; Stroke (engine); B vitamins; Homocysteine; Internal medicine; Renal function; Gastroenterology; Endocrinology","score_opus":0.05588673959660658,"score_gpt":0.3377961441035223,"score_spread":0.28190940450691576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799778697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00232044,0.8437933,0.0010932628,0.12643555,0.011502956,0.000078456134,0.00031597598,0.000055305274,0.014404863],"genre_scores_gemma":[0.020410214,0.77541125,0.0034344436,0.1624469,0.020481518,0.00015622276,0.0004235073,0.000065630666,0.017170426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988751,0.00043150634,0.00012377126,0.00019388381,0.0003138075,0.000062010724],"domain_scores_gemma":[0.9977124,0.001251338,0.00014559274,0.00013270865,0.00048419452,0.0002737701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028763027,0.000579615,0.00081746257,0.00096159807,0.0007597495,0.0019613097,0.0006101034,0.0024026406,0.0061506247],"category_scores_gemma":[0.004871415,0.00024747555,0.00066144904,0.000992563,0.0010859739,0.0022802122,0.0013783087,0.005929253,0.0027921945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064387696,0.00031699202,0.001652726,0.006089019,0.00029997595,0.00030305426,0.00021388137,0.00018385543,0.0020010825,0.016887872,0.22262679,0.74878085],"study_design_scores_gemma":[0.00049250736,0.0008417423,0.003286036,0.0059350403,0.00027880727,0.0005636801,0.00010550437,0.00019651256,0.0011389154,0.017138306,0.96996945,0.00005359254],"about_ca_topic_score_codex":0.002362262,"about_ca_topic_score_gemma":0.0039280085,"teacher_disagreement_score":0.0061506247,"about_ca_system_score_codex":0.0013755889,"about_ca_system_score_gemma":0.0016609227,"threshold_uncertainty_score":0.02057594},"labels":[],"label_agreement":null},{"id":"W2802999705","doi":"10.17925/usn.2018.14.1.47","title":"Edaravone in Amyotrophic Lateral Sclerosis’Lessons from the Clinical Development Program and the Importance of a Strategic Clinical Trial Design","year":2018,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mitsubishi Tanabe Pharma Corporation; Mallinckrodt Pharmaceuticals","keywords":"Edaravone; Amyotrophic lateral sclerosis; Medicine; Clinical trial; Drug development; Clinical study design; Cohort; Disease; Intensive care medicine; Oncology; Pharmacology; Internal medicine; Drug","score_opus":0.45025775534504736,"score_gpt":0.4830974873236365,"score_spread":0.03283973197858914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802999705","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041122944,0.80416334,0.013454839,0.16294788,0.009306047,0.0009690125,0.00017149364,0.000095533724,0.0047796303],"genre_scores_gemma":[0.07207469,0.67389244,0.08426763,0.14952703,0.012612499,0.0041476423,0.00034215732,0.00014636475,0.0029896004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.94427294,0.0456265,0.0038467057,0.0014767383,0.004028655,0.00074847415],"domain_scores_gemma":[0.8904079,0.09041123,0.0037686385,0.0035257326,0.009089971,0.002796448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13109598,0.00068916974,0.0021522278,0.00079300895,0.0006168461,0.0036034868,0.002062977,0.0047049234,0.0018003499],"category_scores_gemma":[0.09495792,0.00040694067,0.0017853335,0.00097293966,0.0037445414,0.003960671,0.0025019478,0.007506285,0.0004803689],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029744906,0.0003010648,0.0013747853,0.013282457,0.0010824692,0.00038479557,0.0006159689,0.0014184852,0.0015477173,0.092463784,0.054979183,0.82957476],"study_design_scores_gemma":[0.007781409,0.0053567057,0.004489246,0.032651085,0.002187116,0.0011078148,0.000520397,0.0019000344,0.002578026,0.12312513,0.8181364,0.00016657666],"about_ca_topic_score_codex":0.0010906387,"about_ca_topic_score_gemma":0.0020841279,"teacher_disagreement_score":0.13109598,"about_ca_system_score_codex":0.0031789278,"about_ca_system_score_gemma":0.014029301,"threshold_uncertainty_score":0.6933101},"labels":[],"label_agreement":null},{"id":"W2944875226","doi":"10.17925/usn.2019.15.1.18","title":"Imaging, Technology, and Parkinson’s Disease","year":2019,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Deep brain stimulation; Medicine; Movement disorders; Dystonia; Essential tremor; Neuromodulation; Parkinson's disease; Neuroimaging; Translational research; Neurosurgery; Neurology; Clinical neuroscience; Neuroscience; Physical medicine and rehabilitation; Disease; Psychology; Psychiatry; Pathology; Internal medicine","score_opus":0.012124010692921676,"score_gpt":0.27244209693065635,"score_spread":0.26031808623773467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944875226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004579086,0.9283756,0.00012774869,0.046819728,0.008256965,0.0000053073254,0.000021439864,0.000018221424,0.015917044],"genre_scores_gemma":[0.010714026,0.9273646,0.00039977318,0.025952194,0.017332705,0.000014177258,0.000056940593,0.000022003194,0.018143712],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992093,0.00020141697,0.00005910471,0.00008740051,0.00034643017,0.000096392396],"domain_scores_gemma":[0.99880064,0.00065667526,0.00010494346,0.000048706526,0.00027442363,0.00011468353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009380933,0.00044749948,0.000457044,0.0015221577,0.00071322994,0.002258608,0.0006736404,0.0028338418,0.009431401],"category_scores_gemma":[0.0026113854,0.00020365481,0.0004285141,0.0011569804,0.0022306521,0.0017685267,0.0010913782,0.0030691016,0.0023475203],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003472311,0.00005018185,0.0009340057,0.0017201453,0.00007731539,0.0006352571,0.0003753581,0.00013966442,0.0008343289,0.033617627,0.6688985,0.29268295],"study_design_scores_gemma":[0.0000069529124,0.000027703882,0.0024618972,0.0015429412,0.000024964344,0.0016655343,0.00032227745,0.000033661698,0.00022494151,0.0137241725,0.97995204,0.000012856329],"about_ca_topic_score_codex":0.0051853326,"about_ca_topic_score_gemma":0.0075868964,"teacher_disagreement_score":0.009431401,"about_ca_system_score_codex":0.0019484932,"about_ca_system_score_gemma":0.0010929805,"threshold_uncertainty_score":0.031551123},"labels":[],"label_agreement":null},{"id":"W32808450","doi":"10.17925/usn.2010.06.01.36","title":"Monoamine Oxidase Type B Inhibitors in the Treatment of Early Parkinson’s Disease","year":2010,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"National Institutes of Health; Ipsen; Teva Pharmaceutical Industries","keywords":"Medicine; Levodopa; Carbidopa; Monoamine oxidase B; Parkinson's disease; Monoamine oxidase; Disease; Selegiline; Pharmacology; Pharmacotherapy; Dopamine; Internal medicine; Enzyme","score_opus":0.025699423578684544,"score_gpt":0.2946161251388231,"score_spread":0.2689167015601386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W32808450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017801613,0.99398637,0.000081845064,0.0013913647,0.00029066196,0.0000050267595,0.000004203537,0.00000669941,0.0024536478],"genre_scores_gemma":[0.014321828,0.9812087,0.00032074586,0.0009738703,0.0010095249,0.000009816469,0.00001030964,0.0000021282126,0.0021430983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997651,0.00008029713,0.00002532584,0.000021321777,0.00008258328,0.0000254326],"domain_scores_gemma":[0.99976677,0.00010503094,0.00004958794,0.000005516348,0.000038483977,0.000034588393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008652037,0.00035346235,0.000673843,0.0007236593,0.00023564033,0.00054843037,0.00038248385,0.0011793902,0.0020899782],"category_scores_gemma":[0.00061486446,0.0001285763,0.00022650628,0.0005620294,0.00028588538,0.00052423246,0.00026334752,0.00091086025,0.0008253759],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005346001,0.00017084206,0.0013111996,0.0035564397,0.00010215485,0.0017994015,0.0001724696,0.0002047018,0.004066651,0.0022723398,0.023594381,0.9622148],"study_design_scores_gemma":[0.00054425164,0.002062387,0.018662365,0.0038411813,0.0003622083,0.013426258,0.00037247813,0.00026130842,0.0036672212,0.0047222557,0.9520417,0.0000364031],"about_ca_topic_score_codex":0.00075413537,"about_ca_topic_score_gemma":0.0020260524,"teacher_disagreement_score":0.0020899782,"about_ca_system_score_codex":0.0004132245,"about_ca_system_score_gemma":0.0004684379,"threshold_uncertainty_score":0.0069916844},"labels":[],"label_agreement":null},{"id":"W4210542383","doi":"10.17925/usn.2009.05.01.75","title":"Advances in Medical Management of Cluster Headache","year":2009,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Medicine; Cluster headache; Sumatriptan; Zolmitriptan; Methysergide; Topiramate; Triptans; Tolerability; Anesthesia; Verapamil; Migraine; Rizatriptan; Epilepsy; Internal medicine; Adverse effect; Agonist","score_opus":0.022875963400549627,"score_gpt":0.3577844737415116,"score_spread":0.334908510340962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210542383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013169652,0.97577935,0.00048153635,0.013021394,0.0014562678,0.0000139106405,0.000027384194,0.00001793616,0.007885189],"genre_scores_gemma":[0.010234428,0.9760751,0.0022232786,0.004051757,0.0058457106,0.000020803924,0.000056378933,0.000006045471,0.0014864344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99920183,0.00026973558,0.000111722395,0.00008194687,0.0002781748,0.00005660277],"domain_scores_gemma":[0.99689865,0.0014981019,0.00032386679,0.0001340926,0.00089089666,0.00025435822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002686738,0.00040607306,0.00062715367,0.0016559307,0.0003479339,0.0009920318,0.00069482345,0.0011059226,0.0053086113],"category_scores_gemma":[0.0036588276,0.00013862211,0.00044978102,0.0011935402,0.0006679075,0.0016183185,0.0006409043,0.0016515668,0.001361162],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020437119,0.00024389544,0.001326612,0.004658763,0.00008382003,0.00036186934,0.0001284899,0.00019282165,0.0006589266,0.005600353,0.03486667,0.9516734],"study_design_scores_gemma":[0.00014781556,0.0005276021,0.0071266876,0.003915582,0.00016721096,0.002161031,0.0002229891,0.00017813983,0.0004494936,0.0063078017,0.9787677,0.000027924574],"about_ca_topic_score_codex":0.0017774801,"about_ca_topic_score_gemma":0.0034201823,"teacher_disagreement_score":0.0053086113,"about_ca_system_score_codex":0.0010245402,"about_ca_system_score_gemma":0.0013895333,"threshold_uncertainty_score":0.017759025},"labels":[],"label_agreement":null},{"id":"W4212945886","doi":"10.17925/usn.2021.17.2.70","title":"Innovative Therapeutic Development Programme for the Treatment of Early Alzheimer's Disease: Lecanemab (BAN2401)","year":2021,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Institute on Aging","keywords":"Disease; Alzheimer's disease; Medicine; Internal medicine","score_opus":0.12047899836111475,"score_gpt":0.36350853864702065,"score_spread":0.2430295402859059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212945886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11197071,0.42375293,0.016467815,0.106603675,0.01949528,0.0021710696,0.0058783693,0.002312174,0.31134805],"genre_scores_gemma":[0.30772895,0.2752835,0.028141608,0.039899316,0.008035456,0.0015807061,0.008303029,0.00036393394,0.3306636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977535,0.000052524516,0.000011779033,0.000030376397,0.00006552909,0.000064413754],"domain_scores_gemma":[0.99973613,0.000029387893,0.000032614204,0.000010701013,0.000058158075,0.00013297326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009903876,0.00047413487,0.00026834285,0.00048774295,0.00036484128,0.00080406026,0.0005952601,0.0009776405,0.015614825],"category_scores_gemma":[0.0004447355,0.0000820096,0.00039884052,0.00025816832,0.0002843094,0.0004884378,0.00072002277,0.00121711,0.005046013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001434302,0.00076742563,0.0008214264,0.0008910613,0.000067987254,0.0005927373,0.00006958227,0.00024143743,0.031165339,0.0068585607,0.14805192,0.8090383],"study_design_scores_gemma":[0.0015687563,0.0036015408,0.005210083,0.00040292993,0.00014343805,0.0017359102,0.000048540554,0.0004771016,0.03437657,0.0021992533,0.9502023,0.00003358598],"about_ca_topic_score_codex":0.0012405302,"about_ca_topic_score_gemma":0.002340688,"teacher_disagreement_score":0.015614825,"about_ca_system_score_codex":0.00083800533,"about_ca_system_score_gemma":0.0016216749,"threshold_uncertainty_score":0.052236855},"labels":[],"label_agreement":null},{"id":"W4246577497","doi":"10.17925/usn.2013.09.01.35","title":"Symptomatic Treatment in Multiple Sclerosis","year":2013,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Spasticity; Quality of life (healthcare); Depression (economics); Disease; Physical medicine and rehabilitation; Balance (ability); Gait; Sexual dysfunction; Physical therapy; Psychiatry; Internal medicine","score_opus":0.12730641820576927,"score_gpt":0.327353612265473,"score_spread":0.20004719405970373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246577497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053126514,0.98425484,0.00032869243,0.0013014316,0.00057379785,0.000034593384,0.000073651914,0.00003331175,0.008087002],"genre_scores_gemma":[0.09059641,0.89888453,0.001538638,0.0030713184,0.0012483196,0.0001397463,0.00032046385,0.000017452445,0.004183186],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978477,0.00007715957,0.000030146815,0.000023135759,0.00006714336,0.000017720302],"domain_scores_gemma":[0.999856,0.000058251644,0.000032149645,0.000005910099,0.000030529784,0.000017129072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036847405,0.00026491817,0.0006556179,0.00062900584,0.0003429168,0.00048926304,0.0003522191,0.0005837607,0.0049259216],"category_scores_gemma":[0.00062586303,0.0000556392,0.00039858944,0.0005158788,0.0001927265,0.00031836051,0.0003526428,0.0007331738,0.00097313244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053437153,0.00027639847,0.00058305997,0.014262885,0.00019237127,0.00054563413,0.00020754144,0.00007870754,0.004463355,0.00186956,0.022073567,0.95491254],"study_design_scores_gemma":[0.0010038664,0.002818943,0.020076009,0.020255089,0.0009916757,0.010734891,0.00041259362,0.00022019267,0.0046138475,0.0056295907,0.93319434,0.000048916983],"about_ca_topic_score_codex":0.0004902224,"about_ca_topic_score_gemma":0.0011571643,"teacher_disagreement_score":0.0049259216,"about_ca_system_score_codex":0.00033557144,"about_ca_system_score_gemma":0.00038742108,"threshold_uncertainty_score":0.016478896},"labels":[],"label_agreement":null},{"id":"W4247336648","doi":"10.17925/usn.2011.07.01.41","title":"Stroke Rehabilitation—An Overview of Existing Guidelines and Standards of Care","year":2011,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rehabilitation; Guideline; Stroke (engine); Best evidence; Health care; Clinical Practice; Alternative medicine; MEDLINE; Physical therapy; Intensive care medicine; Pathology","score_opus":0.20343810368851664,"score_gpt":0.43136387943434895,"score_spread":0.2279257757458323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247336648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026919039,0.8107749,0.017555205,0.12547867,0.0073201237,0.0021872025,0.0027654367,0.0006572417,0.030569196],"genre_scores_gemma":[0.0141931195,0.8438449,0.10670815,0.020406649,0.0024990172,0.0027328513,0.005512888,0.0002134519,0.003889065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9783584,0.0065210355,0.0075147077,0.0006308493,0.006312125,0.0006629661],"domain_scores_gemma":[0.9756939,0.0070456765,0.003421191,0.0006145899,0.012189159,0.0010354923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02241606,0.001351209,0.0023444926,0.0117429355,0.0020784994,0.005210067,0.005207414,0.004722368,0.0044310633],"category_scores_gemma":[0.04477261,0.0009606769,0.002038336,0.0151349995,0.0014542665,0.004321991,0.0027395776,0.0054292963,0.0026840665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008731834,0.00021256464,0.002603891,0.017767759,0.00023755128,0.0003469078,0.00079916,0.0009629626,0.00031543177,0.0098649645,0.28231567,0.68448585],"study_design_scores_gemma":[0.00009088228,0.00013450578,0.0087115625,0.10599421,0.0005148443,0.0010403892,0.0014961129,0.0009865385,0.0003154225,0.009319148,0.87128514,0.00011119679],"about_ca_topic_score_codex":0.023358334,"about_ca_topic_score_gemma":0.0462259,"teacher_disagreement_score":0.023358334,"about_ca_system_score_codex":0.009357534,"about_ca_system_score_gemma":0.029534526,"threshold_uncertainty_score":0.11854887},"labels":[],"label_agreement":null},{"id":"W4249026402","doi":"10.17925/usn.2011.07.02.84","title":"Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis—A Medical, Sociological, and Media Controversy","year":2011,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple sclerosis; Clinical trial; Skepticism; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.10343163843929372,"score_gpt":0.27935728291910067,"score_spread":0.17592564447980696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249026402","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063105887,0.18532625,0.000091696274,0.79154265,0.010576122,0.000007489926,0.00006873572,0.000012293409,0.0060643097],"genre_scores_gemma":[0.16782002,0.27625918,0.00037319644,0.423231,0.12909187,0.00004988482,0.00012422151,0.000045122353,0.0030055305],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9936237,0.0030503408,0.0005596757,0.00068139064,0.0014300545,0.00065489253],"domain_scores_gemma":[0.96097165,0.027768789,0.0040047946,0.00082439964,0.0037591094,0.0026713377],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.011547995,0.00042980356,0.0011147324,0.0052641025,0.008241088,0.011401278,0.0015693031,0.012250318,0.0054425984],"category_scores_gemma":[0.03306953,0.00051233947,0.0007047944,0.0039400943,0.017156716,0.012302431,0.0048940065,0.012818517,0.0011086225],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043733892,0.00027697152,0.01450019,0.0026522367,0.0002284855,0.00426729,0.035963714,0.0001008346,0.0006523223,0.12988098,0.52851576,0.28252396],"study_design_scores_gemma":[0.00013281367,0.00015484991,0.018399486,0.009254384,0.00018943897,0.0072207483,0.028022656,0.00014766274,0.00027450875,0.040655974,0.8953749,0.00017260578],"about_ca_topic_score_codex":0.008390168,"about_ca_topic_score_gemma":0.0074817,"teacher_disagreement_score":0.9917589,"about_ca_system_score_codex":0.0060322266,"about_ca_system_score_gemma":0.0045046834,"threshold_uncertainty_score":0.06107235},"labels":[],"label_agreement":null},{"id":"W4255101771","doi":"10.17925/usn.2012.08.01.12","title":"Deep Brain Stimulation for Parkinson’s Disease—A Review","year":2012,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders; University of British Columbia","funders":"","keywords":"Deep brain stimulation; Medicine; Dyskinesia; Parkinson's disease; Disease; Intervention (counseling); Motor symptoms; Medical therapy; Physical medicine and rehabilitation; Refractory (planetary science); Intensive care medicine; Physical therapy; Neuroscience; Psychiatry; Surgery; Psychology; Pathology","score_opus":0.049194210209526065,"score_gpt":0.344750848154001,"score_spread":0.2955566379444749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255101771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000101866026,0.9988826,0.00006594885,0.00019702419,0.000283406,0.000004194301,0.000003294522,0.0000025707727,0.00045910984],"genre_scores_gemma":[0.00059269456,0.99826604,0.00013275469,0.00029225246,0.00038491221,0.0000060786338,0.000007629827,0.0000012732909,0.0003163114],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997348,0.00006107218,0.00006303985,0.000032887358,0.00009357307,0.000014582658],"domain_scores_gemma":[0.9993524,0.00043799987,0.000075978576,0.000015883352,0.00008796287,0.00002983587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007593268,0.0007694209,0.0013395746,0.001578032,0.000268843,0.0008418618,0.00077479973,0.0011059153,0.0027130754],"category_scores_gemma":[0.001249857,0.00022355701,0.0004725064,0.0018250725,0.00045744106,0.0011581536,0.00040388753,0.001009548,0.0014087678],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007206243,0.000085013526,0.00023487875,0.017539993,0.00013327076,0.00054003706,0.000073733434,0.00032722898,0.0009788119,0.0013652804,0.03356334,0.9450864],"study_design_scores_gemma":[0.000059478574,0.0003235937,0.0029499799,0.023604171,0.00028341622,0.006817166,0.00017177232,0.0002019222,0.00065775256,0.0027741783,0.9621231,0.00003353551],"about_ca_topic_score_codex":0.0009042796,"about_ca_topic_score_gemma":0.0015992549,"teacher_disagreement_score":0.0027130754,"about_ca_system_score_codex":0.00045080134,"about_ca_system_score_gemma":0.00065300945,"threshold_uncertainty_score":0.009076178},"labels":[],"label_agreement":null}]}